Nn9536-4576
Research payments
$5,097,301
Through program year 2022, $5,097,301 in research payments was reported against Nn9536-4576, across 5,188 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $225 | 3 |
| 2021 | Research | $1,058,638 | 213 |
| 2020 | Research | $2,883,886 | 4,114 |
| 2019 | Research | $1,154,552 | 858 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Karen Laufer Miami, FL Named on 327 payments
- Paul Rosenblit Huntington Beach, CA Named on 303 payments
- Philip Odonnell Winchester, VA Named on 300 payments
- Frank Greenway Baton Rouge, LA Named on 282 payments
- Phillip Toth Indianapolis, IN Named on 275 payments
- Domenica Rubino Arlington, VA Named on 266 payments
- John Gilbert Fullerton, CA Named on 264 payments
- David Fitz-Patrick Honolulu, HI Named on 259 payments
- Julio Rosenstock Dallas, TX Named on 257 payments
- Eric Klein Olympia, WA Named on 256 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.